Mohamed Osman, MD
Anesthesiology · Detroit, MINPI 1306954227
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,969 of the $4,369 with a category attached, or 68.0%. 18 manufacturers reported payments, led by Wilson Cook Medical Incorporated at 32.0% of the total. Reporting peaked in 2019 at $1,797 and has fallen 56.1% since, to $790 in 2025. Among anesthesiology clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 71 payments — averaging $61.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Wilson Cook Medical Incorporated$1K
- Medtronic$1K
- Boston Scientific$561
- Nalu Medical, Inc.$231
- GRT US Holding, Inc.$189
- Abbott$173
- plus $484 from 12 others
What the payments were for
- Consulting fees$1,40032%
- Food & beverage$2,96968%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Wilson Cook Medical Incorporated | 1 | $1,400 |
| Medtronic | 26 | $1,331 |
| Boston Scientific | 18 | $561 |
| Nalu Medical, Inc. | 2 | $231 |
| GRT US Holding, Inc. | 5 | $189 |
| Abbott | 2 | $173 |
| Nevro Corp. | 3 | $161 |
| Stryker | 2 | $97 |
| Ultragenyx Pharmaceutical Inc. | 1 | $38 |
| Averitas Pharma Inc. | 2 | $37 |
| Pfizer | 2 | $29 |
| Elutia, Inc. | 1 | $27 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Redhill Biopharma Inc. | 1 | $17 |
| Virtus Pharmaceuticals LLC | 1 | $17 |
| Merck | 1 | $16 |
| Amgen | 1 | $16 |
| Collegium Pharmaceutical, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,369 in reported general payments places this provider in the 95th percentile of 1,299 anesthesiology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 995 | $18,578 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 545 | $12,731 |
| OxycontinOxycodone Hcl | 13 | $7,265 |
| Naloxone Hcl | 100 | $7,142 |
| MovantikNaloxegol Oxalate | 16 | $6,615 |
| Diclofenac Sodium | 111 | $5,850 |
| Gabapentin | 494 | $5,677 |
| Pregabalin | 204 | $2,608 |
| Tizanidine Hcl | 228 | $1,911 |
| Lidocaine | 28 | $1,899 |
| Celecoxib | 106 | $1,042 |
| Cyclobenzaprine Hcl | 164 | $1,031 |
| Ibuprofen | 159 | $1,000 |
| Naproxen | 96 | $924 |
| Morphine Sulfate ErMorphine Sulfate | 48 | $801 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Redhill Biopharma Inc.Movantik | $17 | $6,61516 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,299 anesthesiology providers in Michigan.
Other anesthesiology in Detroit
- Zachary WeinermanDetroit$24K
- Thomas RodziewiczDetroit$15K
- Roger HaddadDetroit$13K
- Peter KhouryDetroit$13K
- Nancy GhalebDetroit$11K
- Carlos Guerra LondonoDetroit$5K
- Joseph HannaDetroit$5K
- Joseph SandersDetroit$5K
- Gaurav ChauhanDetroit$5K
- Amanbir DhadeDetroit$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.